Baxter forced to recall and destroy all Colleague pumps
This article was originally published in SRA
Baxter Healthcare has been ordered by the US Food and Drug Administration to recall and destroy all of its Colleague infusion pumps in the US due to “a longstanding failure to correct many serious problems with the pumps”1,2. The action is expected to cost the company up to $600 million in additional expenses.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals